Melanoma cells with constitutively kinase-active PLK1 showed higher proliferation, migration, and invasion potential (Fig. 3a-c), as well as modulation in EMT markers compared to the kinase-inactive PLK1 expressing cells (Fig. 3d). The gene discussed is PLK1; the disease is melanoma.